157 related articles for article (PubMed ID: 32674121)
1. Comparison of Two Commercially Available Fentanyl Screening Immunoassays for Clinical Use.
Budelier MM; Franks CE; Logsdon N; Jannetto PJ; Scott MG; Roper SM; Farnsworth CW
J Appl Lab Med; 2020 Nov; 5(6):1277-1286. PubMed ID: 32674121
[TBL] [Abstract][Full Text] [Related]
2. Performance Evaluation of an Automated Fentanyl Immunoassay.
Tang MS; Lloyd M; Williams M; Farnsworth CW; Budelier MM
J Appl Lab Med; 2021 Sep; 6(5):1192-1201. PubMed ID: 34263303
[TBL] [Abstract][Full Text] [Related]
3. Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays.
Williams GR; Akala M; Wolf CE
Clin Biochem; 2023 Mar; 113():45-51. PubMed ID: 36610468
[TBL] [Abstract][Full Text] [Related]
4. Performance of Two Fentanyl Immunoassays against a Liquid Chromatography-Tandem Mass Spectrometry Method.
Feng S; Rutledge TJ; Manzoni M; Le T; Gardiner J; Milone M; Shaw L; Wang P
J Anal Toxicol; 2021 Feb; 45(2):117-123. PubMed ID: 32435812
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection.
Lam KHB; Menlyadiev M; Buggs V; Parnprome S; Pesce A; Suhandynata RT; Fitzgerald RL; Song L; Metushi IG
J Appl Lab Med; 2024 Jun; ():. PubMed ID: 38831664
[TBL] [Abstract][Full Text] [Related]
6. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl.
Uljon S; Tolan NV; Mahowald GK; Khaliq T; Urwiller ED; Fernandes MD; Basu SS; Kang P; Erickson TB; Hayes BD; Chai PR; Melanson SEF
J Appl Lab Med; 2024 Apr; ():. PubMed ID: 38656327
[TBL] [Abstract][Full Text] [Related]
7. Performance of Fentanyl Immunoassays in an ED Patient Population.
Mills CM; Dryja PC; Champion-Lyons E; Keppler C; Babic N
J Appl Lab Med; 2024 Mar; ():. PubMed ID: 38517223
[TBL] [Abstract][Full Text] [Related]
8. Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department.
Li Z; Chen H; Feng S; Liu K; Wang P
Clin Chem; 2020 Feb; 66(2):324-332. PubMed ID: 32040576
[TBL] [Abstract][Full Text] [Related]
9. Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair.
Busardò FP; Carlier J; Giorgetti R; Tagliabracci A; Pacifici R; Gottardi M; Pichini S
Front Chem; 2019; 7():184. PubMed ID: 31001514
[TBL] [Abstract][Full Text] [Related]
10. Analysis, identification and confirmation of synthetic opioids using chloroformate chemistry: Retrospective detection of fentanyl and acetylfentanyl in urine and plasma samples by EI-GC-MS and HR-LC-MS.
Valdez CA; Leif RN; Corzett TH; Dreyer ML
PLoS One; 2022; 17(11):e0275931. PubMed ID: 36322521
[TBL] [Abstract][Full Text] [Related]
11. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users.
Ramírez Fernández MDM; Wille SMR; Jankowski D; Hill V; Samyn N
Forensic Sci Int; 2020 Feb; 307():110137. PubMed ID: 31927248
[TBL] [Abstract][Full Text] [Related]
12. Validation and Cross-Reactivity Data for Fentanyl Analogs With the Immunalysis Fentanyl ELISA.
Guerrieri D; Kjellqvist F; Kronstrand R; Gréen H
J Anal Toxicol; 2019 Jan; 43(1):18-24. PubMed ID: 30215771
[TBL] [Abstract][Full Text] [Related]
13. Advances in fentanyl testing.
Uljon S
Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717
[TBL] [Abstract][Full Text] [Related]
14. An LC-MS-MS Method for the Analysis of Carfentanil, 3-Methylfentanyl, 2-Furanyl Fentanyl, Acetyl Fentanyl, Fentanyl and Norfentanyl in Postmortem and Impaired-Driving Cases.
Sofalvi S; Schueler HE; Lavins ES; Kaspar CK; Brooker IT; Mazzola CD; Dolinak D; Gilson TP; Perch S
J Anal Toxicol; 2017 Jul; 41(6):473-483. PubMed ID: 28830122
[TBL] [Abstract][Full Text] [Related]
15. Miniaturized extraction method for analysis of synthetic opioids in urine by microextraction with packed sorbent and liquid chromatography-tandem mass spectrometry.
da Cunha KF; Rodrigues LC; Huestis MA; Costa JL
J Chromatogr A; 2020 Aug; 1624():461241. PubMed ID: 32540079
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021.
Korn WR; Stone MD; Haviland KL; Toohey JM; Stickle DF
Clin Chim Acta; 2021 Oct; 521():151-154. PubMed ID: 34265257
[TBL] [Abstract][Full Text] [Related]
17. Could chest wall rigidity be a factor in rapid death from illicit fentanyl abuse?
Burns G; DeRienz RT; Baker DD; Casavant M; Spiller HA
Clin Toxicol (Phila); 2016 Jun; 54(5):420-3. PubMed ID: 26999038
[TBL] [Abstract][Full Text] [Related]
18. Determination of Fentanyl, Alpha-Methylfentanyl, Beta-Hydroxyfentanyl and the Metabolite Norfentanyl in Rat Urine by LC-MS-MS.
Li L; Yu X; Lyu L; Duan H; Chen Y; Bian J; Xu Z; Liu L; Zhang Y
J Anal Toxicol; 2022 Apr; 46(4):421-431. PubMed ID: 33647104
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay.
Wang BT; Colby JM; Wu AH; Lynch KL
J Anal Toxicol; 2014; 38(9):672-5. PubMed ID: 25248490
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing.
Menlyadiev M; Suhandynata RT; Lund K; Kelner MJ; Fitzgerald RL
J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():105-113. PubMed ID: 37025609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
